surpass cvot tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Cardiovascular Outcomes with Tirzepatide versus

In the lipid profile, the proportion achieving triglyceride levels below 1.7 mmol/l was higher in the tirzepatide-treated groups

At the 10 mg/mL concentration, the starting dose equals 25 units, which is an easy, clean measurement

Tinnitus affects 1015% of adults and can arise from numerous causes including age-related hearing loss, noise exposure, ear infections, cardiovascular conditions, and certain medications

Additionally, the gut microbiota plays an important role in bone metabolism regulation, and supplementing with certain probiotics may have a preventive effect on bone mass reduction associated with TZP treatment